Delta-10-tetrahydrocannabinol (D10-THC): Specs, Where It Fits & Evidence

Cannabinoid · Phytocannabinoid

Delta-10-tetrahydrocannabinol (D10-THC) is a phytocannabinoid made by the cannabis plant, in the THC-type group. A mildly intoxicating THC isomer, mostly lab-converted.

Where it fits

What the research shows

Direct human research on Delta-10-tetrahydrocannabinol (D10-THC) is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.

FAQ

Is D10-THC intoxicating? Its effect is mild.

How is commercial delta-10-THC produced? Because cannabis flowers contain only trace or undetectable quantities of delta-10-THC, commercial products are manufactured in laboratories by chemically isomerizing hemp-derived CBD using acid or basic catalysts and heat.

Why do delta-10-THC lab reports require specialized chromatography? Delta-10-THC exists as (6aR,9R) and (6aR,9S) stereoisomers that co-elute with CBC and delta-6a,10a-THC on basic UV-HPLC methods, requiring chiral LC-MS/MS or GC-MS to verify purity and rule out residual catalyst by-products.

Isomer Chemistry, Stereocenters, and Analytical Evidence

Delta-10-tetrahydrocannabinol (D10-THC) is a positional isomer of delta-9-THC and delta-8-THC in which the alicyclic double bond shifts to the C10-C10a position on the dibenzopyran ring. First characterized as a synthetic base-catalyzed degradation product by Srebnik et al. (1984) (PubMed PMID 6090521), D10-THC possesses two stereocenters at C6a and C9, yielding (6aR,9R) and (6aR,9S) epimers with markedly lower CB1 receptor efficacy than delta-9-THC. In commercial hemp markets, D10-THC is synthesized via acid- or base-mediated isomerization of cannabidiol (CBD), a reaction that frequently generates co-eluting 9-hydroxyhexahydrocannabinol and iso-THC by-products (PubMed PMID 34886311). Consequently, regulatory and forensic toxicology agencies including the U.S. Food and Drug Administration (FDA) and the European Union Drugs Agency (EUDA) highlight uncharacterized reaction residues and chiral separation challenges on standard HPLC assays (PubMed PMID 36689891).

Part of the NOIDS cannabinoids index. Educational reference, not medical advice.